colforsin has been researched along with vinpocetine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Cantabrana, B; Hidalgo, A; Perez-Vallina, JR; Revuelta, MP | 1 |
| Baba, J; Miyashiro, M; Sawa, A; Yamashita, N | 1 |
| Kim, DH; Lerner, A | 1 |
| Aardal, S; Helle, KB; Lillestłl, IK | 1 |
| Sawada, M; Suzumura, A; Takayanagi, T; Tamaru, T; Yoshikawa, M | 1 |
| Nekrassov, V; Sitges, M | 1 |
| Kaneda, T; Nakajyo, S; Shimizu, K; Urakawa, N | 1 |
9 other study(ies) available for colforsin and vinpocetine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Effect of Rp diastereoisomer of adenosine 3',5' cyclic-monophosphothioate on the cAMP-dependent relaxation of smooth muscle.
Topics: Animals; Colforsin; Cyclic AMP; Drug Interactions; Enzyme Inhibitors; Female; Histamine; Muscle Relaxation; Papaverine; Phosphodiesterase Inhibitors; Potassium Chloride; Pyrrolidinones; Rats; Rats, Wistar; Rolipram; Stereoisomerism; Thionucleotides; Uterine Contraction; Uterus; Vanadates; Vinca Alkaloids | 1997 |
Rolipram, a selective inhibitor of phosphodiesterase type 4, pronouncedly enhanced the forskolin-induced promotion of dopamine biosynthesis in primary cultured rat mesencephalic neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Cells, Cultured; Colforsin; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 4; Dopamine; Embryo, Mammalian; Female; Mesencephalon; Neurons; Phosphodiesterase Inhibitors; Pregnancy; Pyrrolidinones; Rats; Rats, Wistar; Rolipram; Vinca Alkaloids | 1997 |
Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Antibodies, Anti-Idiotypic; Antigens, CD19; Antineoplastic Agents; Apoptosis; B-Lymphocytes; Bucladesine; Calcium; Calmodulin; Cells, Cultured; Colforsin; Cyclic AMP; DNA, Complementary; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Interleukin-2; Isoenzymes; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Phosphodiesterase Inhibitors; Polymerase Chain Reaction; Pyrrolidinones; RNA, Messenger; Rolipram; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vinca Alkaloids | 1998 |
Relaxing effects of cyclic GMP and cyclic AMP-enhancing agents on the long-lasting contraction to endothelin-1 in the porcine coronary artery.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Atrial Natriuretic Factor; Caffeine; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Colforsin; Coronary Vessels; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Endothelin-1; In Vitro Techniques; Isradipine; Milrinone; Muscle, Smooth, Vascular; Papaverine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Pyrrolidinones; Rolipram; Swine; Vasoactive Intestinal Peptide; Vasoconstriction; Vasodilation; Verapamil; Vinca Alkaloids | 1998 |
Effects of phosphodiesterase inhibitors on cytokine production by microglia.
Topics: 1-Methyl-3-isobutylxanthine; Amrinone; Animals; Anti-Ulcer Agents; Cilostazol; Colforsin; Dipyridamole; DNA Primers; Gene Expression Regulation, Enzymologic; Interleukin-1; Interleukin-6; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazines; Pyrrolidinones; Quinolines; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Rolipram; Tetrazoles; Theophylline; Tumor Necrosis Factor-alpha; Vinca Alkaloids; Xanthines | 1999 |
Vinpocetine selectively inhibits neurotransmitter release triggered by sodium channel activation.
Topics: Animals; Calcium; Calcium Channels; Colforsin; Corpus Striatum; Cyclic AMP; Male; Neuroprotective Agents; Neurotransmitter Agents; Potassium; Rats; Rats, Wistar; Sodium; Sodium Channels; Synaptosomes; Tetrodotoxin; Veratridine; Vinca Alkaloids | 1999 |
Effects of various selective phosphodiesterase inhibitors on carbachol-induced contraction and cyclic nucleotide contents in guinea pig taenia coli.
Topics: Adenine; Animals; Carbachol; Colforsin; Colon; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Guinea Pigs; Male; Milrinone; Muscle Contraction; Nitroprusside; Nucleotides, Cyclic; Phosphodiesterase Inhibitors; Purinones; Vinca Alkaloids | 2004 |